Mendel Biotechnology Announces Agreement With Monsanto

HAYWARD, Calif., July 10 /PRNewswire/ — Mendel Biotechnology, Inc. (“Mendel”) today announced a new research and commercialization partnership with Monsanto Company (“Monsanto”). The new program represents a significant expansion of the ongoing collaboration between the companies and extends the agreement through 2011. Mendel and Monsanto have agreed not to disclose financial details of the agreement.

Monsanto and Mendel will continue to collaborate on the commercialization by Monsanto of technologies developed by Mendel. In addition, the companies will initiate a systems biology program to develop an integrated framework for predictive control of plant gene expression that is anticipated to streamline discovery and product development activities…

This new partnership extends the relationship initiated in 1997, under which Mendel executed a functional genomics program in the model plant Arabidopsis focused on understanding the factors that control plant gene expression. That program identified a number of genes that have been shown to enhance the yield of major crops in extensive field trials and that are in early commercial development by Monsanto.

Press Release    Source: Mendel Biotechnology, Inc.    July 10, 2006